134 related articles for article (PubMed ID: 21071473)
1. Inflammatory responses predict long-term mortality risk in community-acquired pneumonia.
Guertler C; Wirz B; Christ-Crain M; Zimmerli W; Mueller B; Schuetz P
Eur Respir J; 2011 Jun; 37(6):1439-46. PubMed ID: 21071473
[TBL] [Abstract][Full Text] [Related]
2. Clinical risk scores and blood biomarkers as predictors of long-term outcome in patients with community-acquired pneumonia: a 6-year prospective follow-up study.
Alan M; Grolimund E; Kutz A; Christ-Crain M; Thomann R; Falconnier C; Hoess C; Henzen C; Zimmerli W; Mueller B; Schuetz P;
J Intern Med; 2015 Aug; 278(2):174-84. PubMed ID: 25529395
[TBL] [Abstract][Full Text] [Related]
3. Albumin and C-reactive protein have prognostic significance in patients with community-acquired pneumonia.
Lee JH; Kim J; Kim K; Jo YH; Rhee J; Kim TY; Na SH; Hwang SS
J Crit Care; 2011 Jun; 26(3):287-94. PubMed ID: 21129911
[TBL] [Abstract][Full Text] [Related]
4. Pro-adrenomedullin to predict severity and outcome in community-acquired pneumonia [ISRCTN04176397].
Christ-Crain M; Morgenthaler NG; Stolz D; Müller C; Bingisser R; Harbarth S; Tamm M; Struck J; Bergmann A; Müller B
Crit Care; 2006; 10(3):R96. PubMed ID: 16805922
[TBL] [Abstract][Full Text] [Related]
5. Prospective comparison of three validated prediction rules for prognosis in community-acquired pneumonia.
Aujesky D; Auble TE; Yealy DM; Stone RA; Obrosky DS; Meehan TP; Graff LG; Fine JM; Fine MJ
Am J Med; 2005 Apr; 118(4):384-92. PubMed ID: 15808136
[TBL] [Abstract][Full Text] [Related]
6. Community-acquired pneumonia requiring hospitalisation. Factors of importance for the short-and long term prognosis.
Hedlund J
Scand J Infect Dis Suppl; 1995; 97():1-60. PubMed ID: 8584866
[TBL] [Abstract][Full Text] [Related]
7. Red blood cell distribution width [RDW] and long-term mortality after community-acquired pneumonia. A comparison with proadrenomedullin.
Bello S; Fandos S; Lasierra AB; Mincholé E; Panadero C; Simon AL; Gavin O; De Pablo F; Menendez R; Torres A
Respir Med; 2015 Sep; 109(9):1193-206. PubMed ID: 26205553
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and significance of various scores for pneumonia severity in the management of patients with community-acquired pneumonia in China.
Yang Y; Xu F; Shi LY; Diao R; Cheng YS; Chen XY; Jing JY; Wang XD; Shen HH
Chin Med J (Engl); 2012 Feb; 125(4):639-45. PubMed ID: 22490488
[TBL] [Abstract][Full Text] [Related]
9. Pro-atrial natriuretic peptide and pro-vasopressin for predicting short-term and long-term survival in community-acquired pneumonia: results from the German Competence Network CAPNETZ.
Krüger S; Ewig S; Kunde J; Hartmann O; Suttorp N; Welte T;
Thorax; 2010 Mar; 65(3):208-14. PubMed ID: 20335288
[TBL] [Abstract][Full Text] [Related]
10. Development of a prognostic index for 90-day mortality in patients discharged after admission to hospital for community-acquired pneumonia.
Capelastegui A; España PP; Quintana JM; Bilbao A; Menendez R; Zalacain R; Torres A
Thorax; 2009 Jun; 64(6):496-501. PubMed ID: 19237392
[TBL] [Abstract][Full Text] [Related]
11. PIRO score for community-acquired pneumonia: a new prediction rule for assessment of severity in intensive care unit patients with community-acquired pneumonia.
Rello J; Rodriguez A; Lisboa T; Gallego M; Lujan M; Wunderink R
Crit Care Med; 2009 Feb; 37(2):456-62. PubMed ID: 19114916
[TBL] [Abstract][Full Text] [Related]
12. Obesity paradox in patients with community-acquired pneumonia: Is inflammation the missing link?
Braun N; Hoess C; Kutz A; Christ-Crain M; Thomann R; Henzen C; Zimmerli W; Mueller B; Schuetz P
Nutrition; 2017 Jan; 33():304-310. PubMed ID: 27742103
[TBL] [Abstract][Full Text] [Related]
13. Cause-specific long-term mortality rates in patients recovered from community-acquired pneumonia as compared with the general Dutch population.
Bruns AH; Oosterheert JJ; Cucciolillo MC; El Moussaoui R; Groenwold RH; Prins JM; Hoepelman AI
Clin Microbiol Infect; 2011 May; 17(5):763-8. PubMed ID: 20807226
[TBL] [Abstract][Full Text] [Related]
14. COPD is associated with increased mortality in patients with community-acquired pneumonia.
Restrepo MI; Mortensen EM; Pugh JA; Anzueto A
Eur Respir J; 2006 Aug; 28(2):346-51. PubMed ID: 16611653
[TBL] [Abstract][Full Text] [Related]
15. Community-acquired pneumonia in patients with and without chronic obstructive pulmonary disease.
Molinos L; Clemente MG; Miranda B; Alvarez C; del Busto B; Cocina BR; Alvarez F; Gorostidi J; Orejas C;
J Infect; 2009 Jun; 58(6):417-24. PubMed ID: 19329187
[TBL] [Abstract][Full Text] [Related]
16. Short- and long-term prognosis for middle-aged and elderly patients hospitalized with community-acquired pneumonia: impact of nutritional and inflammatory factors.
Hedlund J; Hansson LO; Ortqvist A
Scand J Infect Dis; 1995; 27(1):32-7. PubMed ID: 7540316
[TBL] [Abstract][Full Text] [Related]
17. Admission D-dimer can identify low-risk patients with community-acquired pneumonia.
Chalmers JD; Singanayagam A; Scally C; Hill AT
Ann Emerg Med; 2009 May; 53(5):633-8. PubMed ID: 19201061
[TBL] [Abstract][Full Text] [Related]
18. [Long-term survival of immunocompetent patients older than 60 years hospitalized for community-acquired pneumonia].
Saldías P F; Maturana O R; Román O F; Díaz P O
Rev Med Chil; 2013 Jul; 141(7):831-43. PubMed ID: 24356731
[TBL] [Abstract][Full Text] [Related]
19. Long-term Prognosis in COPD Exacerbation: Role of Biomarkers, Clinical Variables and Exacerbation Type.
Grolimund E; Kutz A; Marlowe RJ; Vögeli A; Alan M; Christ-Crain M; Thomann R; Falconnier C; Hoess C; Henzen C; Zimmerli W; Mueller B; Schuetz P;
COPD; 2015 Jun; 12(3):295-305. PubMed ID: 25230352
[TBL] [Abstract][Full Text] [Related]
20. Incidence, timing and risk factors associated with 1-year mortality after hospitalization for community-acquired pneumonia.
Adamuz J; Viasus D; Jiménez-Martínez E; Isla P; Garcia-Vidal C; Dorca J; Carratalà J
J Infect; 2014 Jun; 68(6):534-41. PubMed ID: 24534605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
